James Black (pharmacologist)

Sir James Black OM FRS FRSE FRCP
Born	James Whyte Black (1924-06-14)14 June 1924 Uddingston, Lanarkshire, Scotland
Died	22 March 2010(2010-03-22) (aged 85) London, England
Nationality	British
Citizenship	United Kingdom
Alma mater	University of St Andrews
Known for	work towards the use of propranolol and cimetidine
Awards	Lasker Award (1976) FRS (1976)[1] Mullard Award (1978) Artois-Baillet Latour Health Prize (1979) Cameron Prize for Therapeutics of the University of Edinburgh (1980) Nobel Prize for Medicine (1988) Royal Medal (2004)
Scientific career
Fields	Pharmacology
Institutions	University of Malaya University of Glasgow ICI Pharmaceuticals University College London University of St Andrews University of Dundee King's College London
Website	www.nobelprize.org/nobel_prizes/medicine/laureates/1988/black-bio.html

Sir James Whyte Black OM FRS FRSE FRCP (14 June 1924 – 22 March 2010^[2]) was a Scottish physician and pharmacologist. Together with Gertrude B. Elion and George H. Hitchings, he shared the Nobel Prize for Medicine in 1988 for pioneering strategies for rational drug-design, which, in his case, lead to the development of propranolol and cimetidine.^[3][4] Black established a Veterinary Physiology department at the University of Glasgow, where he became interested in the effects of adrenaline on the human heart. He went to work for ICI Pharmaceuticals in 1958 and, while there, developed propranolol, a beta blocker used for the treatment of heart disease.^[5] Black was also responsible for the development of cimetidine, an H2 receptor antagonist, a drug used to treat stomach ulcers.